The policy-practice gap: describing discordances between regulation on paper and real-life practices among specialized drug shops in Kenya

BMC Health Services Research

Catherine Goodman³  Abdinasir Amin⁴  Timothy Abuya¹  Francis Wafula² 

[1] Population Council, Nairobi, Kenya;KEMRI/Wellcome Trust Research Programme, P. O. Box 43640–00100, Nairobi, Kenya;London School of Hygiene and Tropical Medicine, London, UK;ICF International, Nairobi, Kenya

关键词: Kenya;    Drug Shops;    Pharmaceutical Services;    Regulation;   

Others  :  1126427
DOI  :  10.1186/1472-6963-14-394

 received in 2013-01-07, accepted in 2014-09-11,  发布年份 2014

【 摘 要 】

Background

Specialized drug shops (SDSs) are popular in Sub-Saharan Africa because they provide convenient access to medicines. There is increasing interest in how policymakers can work with them, but little knowledge on how their operation relates to regulatory frameworks. This study sought to describe characteristics and predictors of regulatory practices among SDSs in Kenya.

Methods

The regulatory framework governing the Kenya pharmaceutical sector was mapped, and a list of regulations selected for inclusion in a survey questionnaire. An SDS census was conducted, and survey data collected from 213 SDSs from two districts in Western Kenya.

Results

The majority of SDSs did not comply with regulations, with only 12% having a refrigerator and 22% having a separate dispensing area for instance. Additionally, less than half had at least one staff with pharmacy qualification (46%), with less than a third of all interviewed operators knowing the name of the law governing pharmacy.

Regulatory infringement was more common among SDSs in rural locations; those that did not have staff with pharmacy qualifications; and those whose operator did not know the name of the pharmacy law. Compliance was not significantly associated with the frequency of inspections, with over 80% of both rural and urban SDSs reporting an inspection in the past year.

Conclusion

While compliance was low overall, it was particularly poor among SDSs operating in rural locations, and those that did not have staff with pharmacy qualification. This suggested the need for policy to introduce levels of practice in recognition of the variations in resource availability. Under such a system, rural SDSs operating in low-resource setting, and selling a limited range of medicines, may be exempted from certain regulatory requirements, as long as their scope of practice is limited to certain essential services only. Future research should also explore why regulatory compliance is poor despite regular inspections.

【 授权许可】

   
2014 Wafula et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Brieger W, Unwin A, Greer G, Meek S: Interventions to improve the role of medicine sellers in Malaria Case Management for Children in Africa. London, UK & Arlington, VA, USA: The Malaria Consortium and BASICS for the United States Agency for International Development; prepared for Roll Back Malaria's Sub-group for Communication and Training and Malaria Case Management Working Group; 2005.
• [2]HAI: Retail prices of ACTs co-paid by the AMFm and other antimalarial medicines: Ghana, Kenya, Nigeria, Tanzania and Uganda. Health Action International; 2011.
• [3]Ross-Degnan D, Soumerai SB, Goel PK, Bates J, Makhulo J, Dondi N, Sutoto , Adi D, Ferraz-Tabor L, Hogan R: The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies. Health Policy Plan 1996, 11(3):308-318.
• [4]Chuc NT, Larsson M, Do NT, Diwan VK, Tomson GB, Falkenberg T: Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam. J Clin Epidemiol 2002, 55(11):1148-1155.
• [5]Aguwa CN, Ukwe CV, Ekwunife OI: Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy. Pharm World Sci 2008, 30(1):107-110.
• [6]Paulos CP, Nygren CE, Celedon C, Carcamo CA: Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother 2005, 39(5):939-943.
• [7]Wafula F, Goodman C: Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature. Int J Qual Health Care 2010, 22(4):316-323.
• [8]Wafula F, Miriti EM, Goodman CA: Examining characteristics, knowledge and regulatory practices of specialized drug shops in Sub-Saharan Africa: a systematic review of the literature. BMC Health Serv Res 2012, 12(1):223. BioMed Central Full Text
• [9]Afifi NH, Busse R, Harding A: Regulation of Health Services. In Private Participation in Health Services. Edited by Harding A, Preker A. Washington DC: World Bank; 2003.
• [10]Ratanawijitrasin , Wondemagegnehu E: Effective drug regulation: A multicountry study. Geneva: World Health Organization; 2002.
• [11]Attanayake N, Siyambalagoda L: An inquiry into the regulation of pharmaceuticals and medical practice in Sri Lanka. London: Health Economics and Financing Programme (HEFP) working paper 05–03, London School of Hygiene and Tropical Medicine; 2003.
• [12]Kumaranayake L, Mujinja P, Hongoro C, Mpembeni R: How do countries regulate the health sector? Evidence from Tanzania and Zimbabwe. Health Policy Plan 2000, 15(4):357-367.
• [13]Stenson B, Tomson G, Syhakhang L: Pharmaceutical regulation in context: the case of Lao People's Democratic Republic. Health Policy Plan 1997, 12(4):329-340.
• [14]Amin AA, Walley T, Kokwaro GO, Winstanley PA, Snow RW: Reconciling national treatment policies and drug regulation in Kenya. Health Policy Plan 2007, 22(2):111-112.
• [15]Igun UA: Reported and actual prescription of oral rehydration therapy for childhood diarrhoeas by retail pharmacists in Nigeria. Soc Sci Med 1994, 39(6):797-806.
• [16]Smith F: The quality of private pharmacy services in low and middle-income countries: a systematic review. Pharm World Sci 2009, 31(3):351-361.
• [17]Noor AM, Alegana VA, Gething PW, Snow RW: A spatial national health facility database for public health sector planning in Kenya in 2008. Int J Health Geogr 2009, 8(13):13.
• [18]Barnes J, O’Hanlon B, Feeley F, McKeon K, Gitonga N, Decker C: Kenya Private Health Sector Assessment. In Private Sector Partnerships-One project. Bethesda, MD: Abt Associates Inc; 2009.
• [19]Amin AA, Marsh V, Noor AM, Ochola SA, Snow RW: The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop Med Int Health 2003, 8(12):1143-1152.
• [20]Chuma J, Gilson L, Molyneux C: Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban households in Coastal Kenya: an equity analysis. Trop Med Int Health 2007, 12(5):673-686.
• [21]Kwena Z, Sharma A, Wamae N, Muga C, Bukusi E: Provider characteristics among staff providing care to sexually transmitted infection self-medicating patients in retail pharmacies in Kibera slum, Nairobi. Kenya. Sex Transm Dis 2008, 35(5):480-483.
• [22]Molyneux CS, Mung'Ala-Odera V, Harpham T, Snow RW: Maternal responses to childhood fevers: a comparison of rural and urban residents in coastal Kenya. Trop Med Int Health 1999, 4(12):836-845.
• [23]Amin AA, Snow RW: Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J 2005, 4(1):36. BioMed Central Full Text
• [24]Goel PK, Ross-Degnan D, McLaughlin TJ, Soumerai SB: Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya. Int J Qual Health Care 1996, 8(6):519-526.
• [25]Ministry of Planning: Bungoma South District Development Plan 2008–2012. Nairobi: Ministry of State for Planning, National Development and Vision 2030; 2008.
• [26]Ministry of Planning: Kakamega Central District Development Plan 2008–2012. In Nairobi. Ministry of State for Planning, National Development and Vision 2030; 2008.
• [27]Government of Kenyahttp://opendata.go.ke/Poverty/District-Poverty-Data-KIHBS-2005-6/pnvr-waq2 webcite (Accesses August 2012): http://opendata.go.ke/Poverty/District-Poverty-Data-KIHBS-2005-6/pnvr-waq2; webcite 2005
• [28]Wafula F, Molyneux C, Mackintosh M, Goodman C: Protecting the public or setting the bar too high? Understanding the causes and consequences of regulatory actions of front-line regulators and specialized drug shop operators in Kenya. Soc Sci Med 2013, 97:220-227.
• [29]Bursac Z, Gauss H, Williams KD, Hosmer D: A Purposeful Selection of Variables Macro for Logistic Regression. Source Code for Biology and Medicine 2008, 3:17. BioMed Central Full Text
• [30]Hosmer DW, Lemeshow S: Applied Logistic Regression. New York: Wiley; 2000.
• [31]Abuya T: A Comparative Analysis of Malaria Control Programmes Targeting Delivery of Over-the counter Anti-malarial Drugs in Kenya. In December 2008: PhD Thesis. UK: Life Sciences Discipline, The Open University; 2008.
• [32]Tavrow P, Shabahang J, Makama S: Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District. Kenya. Malar J 2003, 2:10. BioMed Central Full Text
• [33]Benham L: Licensure and Competition in Medical Markets. In In Regulating Doctors’ Fees: Competition, Benefits, and Controls Under Medicare, ed. H.E. Frech III. Washington, DC: American Enterprise Institute; 1991:75-90.
• [34]Blevins SA: The Medical Monopoly: Protecting Consumers or Limiting Competition? The Cato Institute; 1995. http://www.cato.org/pub_display.php?pub_id=1105 webcite. Retrieved July 21, 2009
• [35]Svorny S: Licensing Doctors: Do Economists Agree? Econ Journal Watch 2004, 2:279-305.
• [36]Viberg N, Mujinja P, Kalala W, Kumaranayake L, Vyas S, Tomson G, Lundborg CS: STI management in Tanzanian private drugstores: practices and roles of drug sellers. Sex Transm Infect 2009, 85(4):300-307.
• [37]Ngalande-Banda E, Walt G: The private health sector in Malawi: opening Pandora’s box? J Int Dev 1995, 7:403-421.
• [38]Butt ZA, Gilani AH, Nanan D, Sheikh AL, White F: Quality of pharmacies in Pakistan: a cross-sectional survey. Int J Qual Health Care 2005, 17(4):307-313.
• [39]Mazzilli C, Ahmed R, Davis A: The Private Sector and Health: A survey of Somaliland private pharmacies. Mogadishu: UNICEF Somalia, The European Union, Somaliland Pharmaceutical Association; 2009.
• [40]Mujinja P, Mpembeni R, S L: Regulating private drug outlets in Dar es Salaam - perceptions of key stakeholders. In The new public/private mix in health: exploring the changing landscape. Edited by Söderlund N, Mendoza-Arana P, Goudge J. Geneva: Alliance for Heatlh Policy and Systems Research; 2003.
• [41]Adikwu MU: Sales practices of patent medicine sellers in Nigeria. Health Policy Plan 1996, 11(2):202-205.
• [42]Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A: Drug shop regulation and malaria treatment in Tanzania: why do shops break the rules, and does it matter? Health Policy Plan 2007, 22(6):393-403.
• [43]Battersby A, Goodman C, Abondo C, R M: Improving the supply, distribution and use of antimalarial drugs by the private sector in Tanzania. London: Malaria Consortium; 2003.
• [44]Palafox B, Patouillard E, Tougher S, Goodman C, Hanson K: The private commercial sector distribution chain for antimalarial drugs in Nigeria: Findings from a rapid survey. ACTwatch & London School of Hygiene and Tropical Medicine; 2009.
• [45]Ntambwe M, Luwombo I, Djurna O: Who sells drugs in rural Zaire? World Health Forum 1994, 15(1):62-63.
• [46]Wafula F: Understanding the operation and regulation of specialized drug shops in Kenya. London: PhD Thesis. Open University (Milton Keynes) & Department of Public Health and Policy, London School of Hygiene and Tropical Medicine; 2012.
• [47]Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA: Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan 2004, 19(3):177-182.
• [48]Buabeng KO: The Role of the Pharmaceutical Sector in Malaria Control in Ghana. Doctoral dissertation, Publications of the University of Eastern Finland, Dissertations in Health Sciences; 2010.
• [49]Health Research for Action: Review of the Accredited Drug Dispensing Outlets (ADDO) Roll out Programme in Tanzania. Report by Health Research for Action (HERA); 2006.
• [50]Adu-Sarkodie Y, Steiner MJ, Attafuah J, Tweedy K: Syndromic management of urethral discharge in Ghanaian pharmacies. Sex Transm Infect 2000, 76(6):439-442.
• [51]Goel P, Ross-Degnan D, Berman P, Soumerai S: Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med 1996, 42(8):1155-1161.
• [52]Kwena ZA, Sharma A, Muga C, Wamae N, Bukusi EA: Management of simulated patients with sexually transmitted infections by staff of retail pharmacies in Kibera slums of Nairobi. East Afr Med J 2008, 85(9):419-424.